Blog

The Role of Functional Novel Excipients Needed More Than Ever Before

March 2, 2021Cynthia A. ChallenerPharmaceutical Technology, Pharmaceutical Technology-03-02-2021, Volume 45, Issue 3Pages: 24–29 Without an independent approval pathway for novel excipients, true pharmaceutical innovation could be stymied. Excipients are essential to the formulation of drug products because they enable the effective delivery of drug substances and can account for as much as 80–90% of the drug product formulation.......

Read More

Coronavirus Drug and Treatment Tracker

When the Covid-19 pandemic emerged in early 2020, biomedical researchers scrambled to find treatments and drugs that could save the lives of people infected with the coronavirus. Some of these investigations have been clear successes, leading to millions of saved lives. Some are still ongoing, having yet to yield strong evidence of effectiveness. Other drugs......

Read More

Excipients Used In the Manufacture of Tablets

by Pharmapproach Drug products usually contain inactive, non-medicinal substances other than the therapeutic agent(s). These substances are called excipients, and they are intentionally included in a drug product to serve different pharmaceutical purposes, thus ensuring product acceptability in terms of manufacturability, appearance and performance. In tablet formulation, excipients are usually combined at various quantities with the......

Read More

Growing Global Demand for Excipients

by Excipient World Team Consumer demand for new and innovative drug, over-the-counter, and regulated consumer products is helping to fuel the growth of the excipient market. According to American Pharmaceutical Review‘s article, the excipients market could reach $9.9 B by 2021: Building on Strength: Excipient Supply Chain Prepares to Meet Global Demand Posted: December 22, 2017American......

Read More

What to Know About COVID-19 Tests

People often talk about COVID-19 testing like it means only one thing. But in reality, the U.S. Food and Drug Administration (FDA) has so far granted emergency-use authorization to more than 200 different tests meant to detect a current or past infection from SARS-CoV-2, the virus that causes COVID-19. Most recently, the agency made headlines for approving the first such test......

Read More

UPDATED: Pharma COVID-19 Tracker

The latest coronavirus updates and developments impacting the global pharmaceutical supply chain… 25 August: • AstraZeneca dismisses reports it is in talks with the US government over a potential Emergency Use Authorisation for its COVID-19 vaccine, AZD1222. AstraZeneca “has not discussed emergency use authorization with the US government and it would be premature to speculate on......

Read More

Recommendations for Investigational COVID-19 Convalescent Plasma

August 23, 2020FDA issued an EUA for convalescent plasma on August 23, 2020. Please check back for updates to this page in the near future. FDA has issued guidance to provide recommendations to health care providers and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19 (COVID-19 convalescent plasma) during......

Read More

COVID-19: Prevention and control measures in community

Abstract On January 30, 2020, the WHO declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began to characterize it as a pandemic in order to emphasize the gravity of the situation and urge all countries to take action in detecting infection and preventing spread. Unfortunately, there is no......

Read More

Send via WhatsApp